• Quercetin Suppresses NLRP3 Neuroinflammation in LPS-Induced

  2026-07-24

  This study demonstrates that quercetin significantly mitigates depression-like behaviors and cognitive impairments in an LPS-induced mouse model by targeting the NLRP3 inflammasome pathway. The findings highlight quercetin’s potential as a neuroprotective and anti-inflammatory agent with therapeutic implications for major depressive disorder.

• Gestational Nano-Plastics Disrupt Male Reproductive Health v

  2026-07-24

  This study demonstrates that gestational exposure to polystyrene nano-plastics (PS-NPs) leads to significant testicular damage and impaired spermatogenesis in adult male offspring. By integrating transcriptomic and metabolomic analyses within an adverse outcome pathway (AOP) framework, the authors reveal mechanistic insights into intergenerational reproductive toxicity and highlight key molecular disruptions.

• CXCR4-Targeted Theranostics in Lymphoma: Imaging and Therapy

  2026-07-23

  This review synthesizes recent progress in CXCR4-targeted theranostic strategies for lymphoma, highlighting the dual role of CXCR4 as a diagnostic and therapeutic target. It details the development and application of peptide-based radiotracers and antagonists, providing insights into their mechanisms, clinical potential, and research implications for precision oncology.

• MK-5108 (VX-689): Advanced Workflows for Aurora A Inhibition

  2026-07-23

  MK-5108 (VX-689) empowers researchers to dissect cell cycle progression and tumor proliferation with unmatched selectivity for Aurora A kinase. This guide translates breakthrough findings in retinoblastoma into actionable protocols, troubleshooting, and advanced research applications leveraging APExBIO’s highly selective inhibitor.

• Z-WEHD-FMK (SKU A1924): Reliable Caspase Inhibition in Resea

  2026-07-22

  This article addresses persistent laboratory challenges in cell viability, apoptosis, and inflammation research, demonstrating how Z-WEHD-FMK (SKU A1924) delivers reproducible, data-backed inhibition of inflammatory caspases. Scenario-driven Q&A blocks guide scientists through best practices, protocol optimization, and evidence-based vendor selection for advanced caspase pathway analysis.

• MRT68921 ULK1 Kinase Inhibitor: Precision Autophagy Workflow

  2026-07-22

  Unlock robust, nanomolar-range control of autophagy with the selective ULK1/2 inhibitor MRT68921. This guide details practical assay design, experimental troubleshooting, and actionable insights for maximizing specificity and reproducibility in autophagy research.

• Chloroquine Diphosphate: Precision Modulation of Autophagy a

  2026-07-21

  Explore how Chloroquine diphosphate uniquely modulates autophagy and innate immunity in cancer and viral research. This in-depth analysis reveals emerging assay strategies and mechanistic insights not found in standard reviews.

• NBC19: Optimizing NLRP3 Inflammasome Inhibitor Workflows

  2026-07-21

  NBC19 redefines NLRP3 inflammasome inhibitor assays with nanomolar precision, enabling targeted investigation of cytokine release and inflammation signaling. This guide provides actionable protocols, troubleshooting strategies, and workflow enhancements for robust, reproducible results in advanced inflammation research.

• Refining In Vitro Drug Response Evaluation in Cancer Researc

  2026-07-20

  Schwartz's 2022 dissertation provides a rigorous framework for distinguishing between drug-induced proliferative arrest and cell death in cancer models. By clarifying the limitations of conventional viability assays and introducing improved in vitro methods, these findings enable researchers to more accurately assess anti-proliferative and apoptosis-inducing agents, enhancing preclinical rigor and translational relevance.

• Birinapant (TL32711): Optimizing Apoptosis Induction Workflo

  2026-07-20

  Birinapant (TL32711) empowers cancer researchers with superior control over apoptosis induction, overcoming resistance barriers in vitro and in vivo. This guide translates the latest evidence into actionable workflows, troubleshooting, and protocol enhancements for high-sensitivity studies.

• PD 0332991 and Cisplatin: Reversing NSCLC Resistance Mechani

  2026-07-19

  This study demonstrates that PD 0332991 (Palbociclib) HCl, a selective CDK4/6 inhibitor, can enhance cisplatin efficacy and reverse acquired cisplatin resistance in nonsmall cell lung cancer (NSCLC) cells. By targeting the Rb-E2F pathway and inducing cell cycle arrest, the combination therapy offers a promising strategy for overcoming chemoresistance in NSCLC.

• Viral Inducers of RIPK3 Degradation Shape Necroptosis and In

  2026-07-18

  Liu et al. identify and characterize a class of viral proteins in orthopoxviruses that induce proteasome-mediated degradation of the necroptosis adaptor RIPK3. This mechanism regulates virus-induced inflammation and pathogenesis, providing new insights into host-virus interactions and experimental strategies for dissecting cell death pathways.

• Reversine in High-Content Cancer Research: From Aurora Kinas

  2026-07-17

  Explore how Reversine, a potent Aurora kinase inhibitor, is revolutionizing high-content cancer research. This article uniquely bridges advanced kinase inhibition with next-generation single-cell assay technologies, offering new insights not covered by existing resources.

• PD 0332991 (Palbociclib) HCl: Enhancing Tumor Growth Suppres

  2026-07-17

  PD 0332991 (Palbociclib) HCl empowers researchers with precise, reproducible cell cycle arrest and robust antiproliferative effects against Rb-positive cancer models. Here, we translate cutting-edge mechanistic insights—including mitochondrial apoptosis signaling—into rigorous experimental workflows, troubleshooting strategies, and future research perspectives.

• Bay 11-7085: NF-κB Activation Inhibitor for Inflammation Mod

  2026-07-16

  Bay 11-7085 enables precise control of NF-κB-driven inflammation and apoptosis in cellular and animal models, making it indispensable for dissecting complex inflammatory pathways. Optimized protocols, troubleshooting tactics, and recent cross-disciplinary insights empower users to achieve superior reproducibility and mechanistic clarity.

13889 records 1/926 page Next 12345 下5页 Last page